<SUBMISSION>
<SECRELEASE-DATETIME> 20171108-080623 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20171108-080623 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20171108-080540 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0000882104-17-000107
<TYPE> 8-K
<PUBLIC-DOCUMENT-COUNT> 3
<PERIOD> 20171108
<ITEMS> 7.01
<ITEMS> 9.01
<FILING-DATE> 20171108
<DATE-OF-FILING-DATE-CHANGE> 20171108
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> PDL BIOPHARMA, INC.
<CIK> 0000882104
<ASSIGNED-SIC> 2836
<IRS-NUMBER> 943023969 ⇒ 94-3023969
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> 8-K
<ACT> 34
<FILE-NUMBER> 000-19756
<FILM-NUMBER> 171185146
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 932 SOUTHWOOD BLVD
<CITY> INCLINE VILLAGE
<STATE> NV
<ZIP> 89451
<PHONE> 775-832-8500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 932 SOUTHWOOD BLVD
<CITY> INCLINE VILLAGE
<STATE> NV
<ZIP> 89451
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> PROTEIN DESIGN LABS INC/DE
<DATE-CHANGED> 19930328
</FORMER-COMPANY>
</FILER>
|
<DOCUMENT>
<TYPE> 8-K
<SEQUENCE> 1
<FILENAME> pdli-201711088xkdoc.htm
<DESCRIPTION> 8-K
<TEXT>
<html>
Show <HTML>: 10 lines (widest: 27,175 characters) - 27K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> EX-99.1
<SEQUENCE> 2
<FILENAME> pdli-201711088xkex991.htm
<DESCRIPTION> PRESS RELEASE
<TEXT>
<html>
Show <HTML>: 10 lines (widest: 12,487 characters) - 13K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 3 ⇐ Not a Document/Exhibit
<FILENAME> pdllogoeaa05.jpg
<TEXT>
Show <TEXT>: 477 lines (Unix-to-Unix encoding) - 29K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
